Zdrowie i gospodarka · 21/12/2023

FDA Requests Public Comment on Proposed Study of Direct-to-Consumer Prescription Drug Promotion

The US Food and Drug Administration (FDA) is seeking public input on a proposed study examining implied claims in direct-to-consumer prescription drug advertising, as required by the Paperwork Reduction Act of 1995.